Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

ClinicalTrials.gov ID: NCT00000849

Public ClinicalTrials.gov record NCT00000849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I/II Trial of Recombinant Interleukin-2 In Symptomatic Human Immunodeficiency Virus-Infected Children

Study identification

NCT ID
NCT00000849
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
27 participants

Conditions and interventions

Conditions

Interventions

  • Aldesleukin Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Feb 28, 2001
Last update posted
Oct 28, 2021

Ends 2001

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach California 90801
UCSF Pediatric AIDS CRS San Francisco California 941430105
Univ. of Colorado Denver NICHD CRS Aurora Colorado 802181088
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209
Chicago Children's CRS Chicago Illinois 606143394
Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago Illinois 606371470
Tulane/LSU Maternal/Child CRS New Orleans Louisiana 701122699
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts 021155724
NYU Med. Ctr., Dept. of Medicine New York New York 10016
Columbia IMPAACT CRS New York New York 10032
Incarnation Children's Ctr. New York New York 10032
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania 191044318
Texas Children's Hosp. CRS Houston Texas 77030
VCU Health Systems, Dept. of Peds Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →